{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:22:48Z","timestamp":1780471368478,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jacadv.2024.101370","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:26:15Z","timestamp":1730096775000},"page":"101370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation"],"prefix":"10.1016","volume":"3","author":[{"given":"Shelby D.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5169-117X","authenticated-orcid":false,"given":"Josephine L.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-9507","authenticated-orcid":false,"given":"Daniel P.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir F.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Alan","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Frisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Viethen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardi","family":"Mundl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Coppolecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Marcos","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2024.101370_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2022.12.006","article-title":"Quantitative benefit-risk assessment in medical product decision making: a good practices report of an ISPOR Task Force","volume":"26","author":"Tervonen","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.jacadv.2024.101370_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/11539660-000000000-00000","article-title":"Using best-worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in Australia","volume":"3","author":"Louviere","year":"2010","journal-title":"Patient"},{"key":"10.1016\/j.jacadv.2024.101370_bib5","series-title":"Asking Questions: A Practical Guide to Questionnaire Design","author":"Sudman","year":"1982"},{"key":"10.1016\/j.jacadv.2024.101370_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/00049537308255849","article-title":"The measurement of values: effects of different assessment procedures","volume":"25","author":"Feather","year":"1973","journal-title":"Aust J Psychol"},{"key":"10.1016\/j.jacadv.2024.101370_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jacadv.2024.101370_bib8","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jacadv.2024.101370_bib9","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified Rankin Scale global disability outcomes: consensus recommendations from stroke therapy academic Industry roundtable XI","volume":"52","author":"Saver","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacadv.2024.101370_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vhri.2015.03.016","article-title":"Comparing patient and physician risk tolerance for bleeding events associated with anticoagulants in atrial fibrillation-evidence from the United States and Japan","volume":"6","author":"Okumura","year":"2015","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.jacadv.2024.101370_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11096-017-0440-8","article-title":"Patient preferences regarding atrial fibrillation stroke prophylaxis in patients at potential risk of atrial fibrillation","volume":"39","author":"Edwards","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jacadv.2024.101370_bib12","first-page":"465","article-title":"Evaluation of patients\u2019 attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"Lahaye","year":"2014","journal-title":"Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101370_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1467-842X.00274","article-title":"The use of balanced incomplete block designs in designing randomized response surveys","volume":"45","author":"Smith","year":"2003","journal-title":"Aust N Z J Statistics"},{"key":"10.1016\/j.jacadv.2024.101370_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40271-019-00360-3","article-title":"A\u00a0Guide to measuring and interpreting attribute importance","volume":"12","author":"Gonzalez","year":"2019","journal-title":"Patient"},{"key":"10.1016\/j.jacadv.2024.101370_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2307\/1924536","article-title":"On approximating the statistical properties of elasticities","volume":"68","author":"Krinsky","year":"1986","journal-title":"Rev Econ Stat"},{"key":"10.1016\/j.jacadv.2024.101370_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1258\/1355819011927288","article-title":"How patients with atrial fibrillation value different health outcomes: a standard gamble study","volume":"6","author":"Robinson","year":"2001","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.jacadv.2024.101370_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1160\/TH16-10-0787","article-title":"Patient values and preferences for antithrombotic therapy in atrial fibrillation. A Narrative Systematic Review","volume":"117","author":"Loewen","year":"2017","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jacadv.2024.101370_bib18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s11239-019-01915-9","article-title":"Assessing patient preferences for switching from warfarin to direct oral anticoagulants","volume":"48","author":"Wright","year":"2019","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacadv.2024.101370_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jval.2016.01.001","article-title":"Physician and patient preferences for nonvalvular atrial fibrillation therapies","volume":"19","author":"Shafrin","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jacadv.2024.101370_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-019-0765-1","article-title":"Introducing a new estimator and test for the weighted all-cause hazard ratio","volume":"19","author":"Ozga","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jacadv.2024.101370_bib21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0962280211436004","article-title":"Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials","volume":"24","author":"Bakal","year":"2015","journal-title":"Stat Methods Med Res"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24006501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24006501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T02:39:24Z","timestamp":1737772764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X24006501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2772963X24006501"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101370","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101370"}}